Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
- SOUTH JORDAN, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the Wrapsody Cell-Impermeable Endoprosthesis (CIE) received regulatory approval from Health Canada. With this approval, Merit intends to begin immediate commercialization of the device throughout Canada with devices shipped from Merit's Toronto distribution center.
- 05/06/2025
|
LH vs. MMSI: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Labcorp (LH) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
- 05/05/2025
|
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
- In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months. In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at 12 months.
- 05/05/2025
|
MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up
- Merit Medical benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter of 2025.
- 04/25/2025
|
Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q1 2025 Results Conference Call April 24, 2025 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Raul Parra - Chief Financial Officer and Treasurer Brian Lloyd - Chief Legal Officer & Corporate Secretary Conference Call Participants Jason Bednar - Piper Sandler Steve Lichtman - Oppenheimer Robbie Marcus - J.P. Morgan Craig Bijou - Bank of America Securities David Rescott - Baird Michael Petusky - Barrington Research Jim Sidoti - Sidoti & Company Jon Young - Canaccord Mike Matson - Needham Jayson Bedford - Raymond James Operator Welcome to the Merit Medical Systems First Quarter 2025 Earnings Conference Call.
- 04/25/2025
|
Compared to Estimates, Merit Medical (MMSI) Q1 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 04/24/2025
|
Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates
- Merit Medical (MMSI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.77 per share a year ago.
- 04/24/2025
|
What Analyst Projections for Key Metrics Reveal About Merit Medical (MMSI) Q1 Earnings
- Beyond analysts' top -and-bottom-line estimates for Merit Medical (MMSI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
- 04/21/2025
|
Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?
- Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/18/2025
|
Merit Medical (MMSI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Merit Medical (MMSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/17/2025
|
Merit Medical Stock Slips Despite the Launch of New Ventrax System
- MMSI launches the Ventrax Delivery System, enhancing pulmonary access procedures with improved control, precision, and efficiency for interventionalists.
- 04/15/2025
|
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
- Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.
- 04/14/2025
|
Merit Medical (MMSI) Surges 8.3%: Is This an Indication of Further Gains?
- Merit Medical (MMSI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 04/10/2025
|
Merit Medical Launches the Ventrax™ Delivery System
- Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia
- 04/09/2025
|
ALGN or MMSI: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
- 04/08/2025
|
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
- SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2025, after the close of the stock market on Thursday, April 24, 2025. Merit plans to hold its investor conference call on the same day (Thursday, April 24, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).
- 04/07/2025
|
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
- Merit Medical's strong product portfolio raises optimism about the stock.
- 04/01/2025
|
Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD
- Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms. Endoscopic anti-reflux therapy recognized as evidence-based approach to providing relief of GERD symptoms.
- 03/27/2025
|
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results
- MMSI unveils 12-month efficacy data for WRAPSODY CIE, highlighting its advanced technology in vascular access maintenance and potential to improve patient outcomes.
- 03/26/2025
|
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
- SOUTH JORDAN, Utah, March 25, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that the six-month results from the randomized arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) trial are scheduled for publication in the April issue of Kidney International . Twelve-month results from the randomized arm of the WAVE trial are scheduled for presentation at the Society of Interventional Radiology's 50th Annual Scientific Meeting in Nashville, TN. The podium presentation is scheduled for March 30, 2025, during the late-breaking trials session.
- 03/25/2025
|
Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership
- SOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred Lampropoulos, will visit the Nasdaq MarketSite in Times Square to ring the opening bell on Wednesday, March 19, 2025. The ceremony begins at 9:15 A.M. (EDT) and the bell ringing takes place at 9:30 A.M.
- 03/18/2025
|
Merit Medical: A Success Story That Keeps Getting Better
- Merit Medical continues to outperform, with the share price supported by on-target financial results, incremental M&A, and positive clinical data. The company's Wrapsody stent graft showed almost best-case clinical efficacy, positioning it to capture significant market share in dialysis graft occlusion procedures. Recent acquisitions, including EsophyX Z+ and Cook Medical's lead management portfolio, enhance Merit's product portfolio and offer longer-term synergies.
- 03/16/2025
|
MMSI Announces Commencement of Patient Enrollment in PREEMIE Study
- Merit Medical aims to improve care for vulnerable premature infants by evaluating the safety and efficacy of the Bloom Micro Occluder System for treating PDA in the specified patient pool.
- 03/14/2025
|
First Patient Enrolled in Merit Medical's PREEMIE Study
- Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants
- 03/10/2025
|
Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript
- Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript
- 02/25/2025
|
Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/25/2025
|
Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates
- Merit Medical (MMSI) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.81 per share a year ago.
- 02/25/2025
|
Merit Medical Reports Fourth Quarter and Full Year 2024 Results and Issues Fiscal Year 2025 Guidance
- Fourth Quarter Highlights† Reported revenue of $355.2 million, up 9.4% Constant currency revenue* and constant currency revenue, organic* up 10.1% and up 6.1%, respectively GAAP operating margin of 10.3%, compared to 10.4% in prior year period Non-GAAP operating margin* of 19.6%, compared to 16.6% in prior year period GAAP EPS $0.46, down 2.6%, Non-GAAP EPS* $0.93, up 25.8%, and Free cash flow* generation of $65.3 million, up 18.4% Fiscal Year 2024 Highlights† Reported revenue of $1.357 billion, up 7.9% Constant currency revenue* and constant currency revenue, organic* up 8.5% and up 6.0%, respectively GAAP operating margin of 11.5 %, compared to 9.9% in prior year Non-GAAP operating margin* of 19.0%, compared to 17.2% in prior year GAAP EPS $2.03, up 25.3%, Non-GAAP EPS* $3.46, up 21.3%, and Free cash flow* generation of $185.7 million, up 67.5% Fourth Quarter Business Developments Completed the acquisition of lead management portfolio of medical devices and certain related assets from Cook Medical Holdings, LLC Announced FDA premarket approval of the Wrapsody® Cell-Impermeable Endoprosthesis device, which is intended to extend long-term vessel patency in dialysis patients Substantially completed integration of the production, distribution and sale of the EsophyX® Z+ device previously acquired from Endogastric Solutions, Inc. Fiscal Year 2025 Guidance Revenue of $1.470 billion to $1.490 billion, up 8% - 10% year-over-year Non-GAAP EPS of $3.58 to $3.70, up 4% - 7% year-over-year † Comparisons noted in the bullet points are calculated for the current quarter compared with the fourth quarter of 2023 or for the current year compared with fiscal year 2023, as applicable, unless otherwise specified. Amounts in this release are rounded while percentages are calculated from the underlying amounts.
- 02/25/2025
|
Gear Up for Merit Medical (MMSI) Q4 Earnings: Wall Street Estimates for Key Metrics
- Evaluate the expected performance of Merit Medical (MMSI) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 02/24/2025
|
Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now
- Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
- 02/21/2025
|
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 02/07/2025
|
Looking for a Growth Stock? 3 Reasons Why Merit Medical (MMSI) is a Solid Choice
- Merit Medical (MMSI) possesses solid growth attributes, which could help it handily outperform the market.
- 02/05/2025
|
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 02/03/2025
|
Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?
- Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/29/2025
|
Merit Medical Systems, Inc. (MMSI) Hits Fresh High: Is There Still Room to Run?
- Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 01/29/2025
|
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 01/22/2025
|
3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)
- Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
- 01/20/2025
|
BDX or MMSI: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
- 01/17/2025
|
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 01/17/2025
|
Merit Medical Stock Gains Following Solid Preliminary Q4 Revenues
- MMSI's revenue growth in the fourth quarter is likely to have been boosted by continued robust adoption of its products.
- 01/15/2025
|
Merit Medical Announces Preliminary Unaudited Revenue for the Year Ended December 31, 2024 and Plans to Announce Fourth Quarter and Year End 2024 Results and Issue Fiscal Year 2025 Guidance on February 25, 2025
- * Constant currency revenue is a non-GAAP financial measure. A reconciliation of this financial measure to its most directly comparable GAAP financial measure is included under the heading “Non-GAAP Financial Measure” below.
- 01/13/2025
|
Is Merit Medical (MMSI) a Solid Growth Stock? 3 Reasons to Think "Yes"
- Merit Medical (MMSI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 01/02/2025
|
Here's Why You Should Add MMSI Stock to Your Portfolio Now
- Merit Medical's strong product portfolio raises optimism about the stock.
- 01/02/2025
|
BDX vs. MMSI: Which Stock Is the Better Value Option?
- Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
- 01/01/2025
|
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 01/01/2025
|
Merit Medical Stock Rises Following FDA Nod for WRAPSODY Device
- MMSI announces FDA approval for the WRAPSODY Cell-Impermeable Endoprosthesis.
- 12/23/2024
|
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
- SOUTH JORDAN, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that the WRAPSODY® Cell-Impermeable Endoprosthesis has received premarket approval from the US Food and Drug Administration (FDA). With this approval, Merit can begin commercialization of the device in the USA in 2025.
- 12/20/2024
|
Merit Medical Announces Resignation of President, Joseph Wright
- SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI) (“Merit” or the “Company”), a global leader of healthcare technology, today announced the resignation of its President, Joseph C. Wright, effective January 3, 2025.
- 12/16/2024
|
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 12/16/2024
|
Zacks Industry Outlook Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems
- Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems have been highlighted in this Industry Outlook article.
- 12/13/2024
|
4 Stocks to Watch Amid Dental Supplies Industry Challenges
- Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are BDX, MCK, CAH and MMSI.
- 12/12/2024
|
MMSI or WST: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?
- 11/29/2024
|
MMSI Stock Down Despite Latest Positive Data From WRAPSODY WAVE Trial
- The significant improvement in patency rates for AVG patients via Merit Medical's WRAPSODY device is expected to enhance patients' vascular access survival.
- 11/26/2024
|
Fundus Camera Market Global Forecasts and Company Analysis 2025-2033, Profiles of Carl Zeiss Medites, Topcon Medical Systems, Merit Medical Systems, NIDEK, and Revenio Group
- Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Fundus Camera Market Global Forecast Report by Product Type, End-User, Countries and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Fundus Camera market was valued at US$459.40 million in 2024 and is anticipated to hit US$665.85 million by 2033 from 2025 to 2033 with a compound annual growth rate of 4.21%. The primary reason for this growth stems from the demand for more developed diagnostics within the eyes, mainly because of retinal disorders that have been on the rise across the globe. A fundus camera is a medical imaging device specific in the application of ophthalmology to capture high resolution images of the internal eye, with emphasis on the retina, optic disc, and macula. It illuminates and photographs the retina through the pupil to provide critical details necessary for diagnostics and management procedures in various eye conditions. Fundus cameras thus play an instrumental role in detecting retinal disorders including diabetic retinopathy, glaucoma, age-related macular degeneration, and retinal detachment. These conditions often progress in a gradual manner but may go unnoticed until they start impairing vision seriously. In that case, early detection via the use of fundus photography will give time to intervene before more serious vision loss takes place. There are mydriatic, non-mydratic, and hybrid types available, and there are also handheld or portable types for easier access. Apart from diagnosis, follow up of disease progression and effectiveness of the treatment being provided makes fundus imaging a tool more essential in eye care. Growth Drivers for the Fundus Camera Market
- 11/25/2024
|
Merit Medical's WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
- WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trial
- 11/25/2024
|
3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)
- Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.
- 11/21/2024
|
Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?
- MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.
- 11/20/2024
|
Merit Medical Systems, Inc. (MMSI) Hits Fresh High: Is There Still Room to Run?
- Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 11/08/2024
|
BDX or MMSI: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
- 11/07/2024
|
Is Merit Medical (MMSI) a Solid Growth Stock? 3 Reasons to Think "Yes"
- Merit Medical (MMSI) possesses solid growth attributes, which could help it handily outperform the market.
- 11/05/2024
|
Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 11/01/2024
|
Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical
- SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook Medical's lead management portfolio. The purchase consideration consisted of a cash payment of approximately $210 million and the assumption of certain liabilities. Merit funded the acquisition payment through a combination of cash on hand and borrowings under its long-term credit facility.
- 11/01/2024
|
MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin
- Merit Medical benefits from revenue growth in both segments and all its product categories within its Cardiovascular unit in the third quarter.
- 10/31/2024
|
Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants John Young - Canaccord Jayson Bedford - Raymond James Jason Bednar - Piper Sandler David Rescott - R.W. Baird Mike Matson - Needham Craig Bijou - Bank of America Securities Jim Sidoti - Sidoti & Company Michael Petusky - Barrington Research Steve Lichtman - Oppenheimer Operator Good day, and thank you for standing by.
- 10/30/2024
|
Compared to Estimates, Merit Medical (MMSI) Q3 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 10/30/2024
|
Merit Medical (MMSI) Q3 Earnings and Revenues Surpass Estimates
- Merit Medical (MMSI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.75 per share a year ago.
- 10/30/2024
|
BDX vs. MMSI: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
- 10/22/2024
|
Why Merit Medical (MMSI) is Poised to Beat Earnings Estimates Again
- Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/21/2024
|
Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
- SOUTH JORDAN, Utah, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2024, after the close of the stock market on Wednesday, October 30, 2024.
- 10/08/2024
|
Merit Medical Stock Gains 24.7% Year to Date: What's Behind the Rally?
- MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.
- 10/08/2024
|
Here's Why You Should Retain Merit Medical Stock in Your Portfolio
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 10/04/2024
|
MMSI Stock Likely to Gain From Cook Medical's Product Portfolio Buyout
- Merit Medical expects to solidify its foothold in the underpenetrated global lead management market via the latest asset acquisition.
- 09/19/2024
|
Merit Medical Stock Falls Despite Positive WRAPSODY Trial Results
- MMSI announces 6-month results from its WRAPSODY WAVE trial, showing superior efficacy in extending AV fistula patency for dialysis patients.
- 09/18/2024
|
Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical
- SOUTH JORDAN, Utah, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced it has signed a definitive asset purchase agreement to purchase Cook Medical's lead management portfolio for total cash consideration of approximately $210 million. Merit expects to fund the transaction through a combination of cash on hand and borrowings under its long-term credit facility. The closing of the proposed transaction is expected to occur during the fourth quarter of 2024, subject to the receipt or waiver (in accordance with the provisions of the asset purchase agreement) of certain closing conditions, including clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, and other customary closing conditions.
- 09/17/2024
|
Merit Medical's WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients
- In the US pivotal trial, WRAPSODY achieved 89.8% target lesion primary patency at 6 months In the US pivotal trial, WRAPSODY achieved 89.8% target lesion primary patency at 6 months
- 09/16/2024
|
Merit Medical Gains 26.4% Year to Date: What's Driving the Stock?
- MMSI's shares gain on the back of strength in its Cardiovascular segment and a robust product portfolio.
- 09/13/2024
|
Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress
- SOUTH JORDAN, Utah, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that clinicians will present updates on two of its pivotal studies during scientific sessions held on September 14 at CIRSE in Lisbon, Portugal.
- 09/11/2024
|
Merit Medical Systems, Inc. (MMSI) Q2 2024 Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q2 2024 Results Conference Call August 1, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman, and Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Mike Matson - Needham Larry Biegelsen - Wells Fargo Steve Lichtman - Oppenheimer David Rescott - Baird Jayson Bedford - Raymond James Craig Bijou - Bank of America Securities John Young - Canaccord Jim Sidoti - Sidoti & Company Operator Ladies and gentlemen, thank you for standing by. Welcome to the Merit Medical Systems Second Quarter 2024 Earnings Conference Call.
- 08/03/2024
|
Merit Medical (MMSI) Q2 Earnings & Revenues Beat, '24 View Up
- Merit Medical's (MMSI) second-quarter results reflect growth in earnings and revenues. Operating margin expands.
- 08/02/2024
|
Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Merit Medical (MMSI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/01/2024
|
Merit Medical (MMSI) Q2 Earnings and Revenues Beat Estimates
- Merit Medical (MMSI) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.81 per share a year ago.
- 08/01/2024
|
Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance
- Second Quarter 2024 Highlights† Reported revenue of $338.0 million, up 5.6% Constant currency revenue* up 6.6% Constant currency revenue, organic,* up 5.0% GAAP operating margin of 13.6%, compared to 9.0% in prior year period Non-GAAP operating margin* of 20.1%, compared to 19.1% in prior year period GAAP EPS $0.61, up 75.7% Non-GAAP EPS* $0.92, up 16.8% † Comparisons noted in the bullet points are calculated for the current quarter compared with the same prior year period unless otherwise specified. * The constant currency revenue; constant currency revenue, organic; non-GAAP gross profit and margin; non-GAAP operating income and margin; non-GAAP net income; non-GAAP EPS; and free cash flow figures (used here and below) are non-GAAP financial measures.
- 08/01/2024
|
Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings
- SOUTH JORDAN, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced plans to release findings from its WAVE study. A pivotal, international, multicenter trial, the WAVE study examines the safety and efficacy of Merit's WRAPSODY Cell-Impermeable Endoprosthesis for treatment of stenosis in the venous outflow circuit.
- 08/01/2024
|
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
- Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
- 07/23/2024
|
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
- Merit Medical's (MMSI) latest asset acquisition is likely to expand its endoscopy portfolio with a minimally-invasive solution for GERD patients, thereby improving patient outcomes.
- 07/03/2024
|
Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?
- Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.
- 07/01/2024
|
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
- SOUTH JORDAN, Utah, July 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million. EndoGastric Solutions' EsophyX® Z+ device delivers a durable, minimally invasive non-pharmacological treatment option for patients suffering from GERD.
- 07/01/2024
|
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 06/28/2024
|
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 06/24/2024
|
Merit Medical (MMSI) Recalls Syringes Made by Jiangsu Shenli
- Merit Medical (MMSI) recalls certain products containing syringes made by a Chinese manufacturer, Jiangsu Shenli.
- 06/18/2024
|
Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
- SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2024, after the close of the stock market on Thursday, August 1, 2024.
- 06/18/2024
|
Merit Medical: Undervalued With Multiple Growth Drivers In Play
- Merit Medical has shown solid performance with revenue and EBITDA growth, but has only tracked the broader med-tech market higher as investors wait for more exciting drivers. The company's WRAPSODY endovascular stent graft has potential to exceed management's projections, and could be a practice-changing $100M+ product with good clinical data. Merit's December 2023 convertible debt offering was well in excess of corporate needs, which leads me to believe that M&A is back on the table.
- 06/15/2024
|
Merit Medical recalling plastic syringes supplied by Jiangsu Shenli Medical, US FDA says
- The U.S. Food and Drug Administration said on Friday that Merit Medical Systems has initiated a recall for plastic syringes supplied by Jiangsu Shenli Medical Production.
- 06/14/2024
|
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 06/11/2024
|
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 06/07/2024
|
Merit Medical (MMSI) Up 5% Since Last Earnings Report: Can It Continue?
- Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock?
- 05/30/2024
|
Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 05/23/2024
|
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
- Merit Medical's (MMSI) latest offering is likely to create an efficient approach to inflation, thereby providing improved patient care.
- 05/22/2024
|
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 05/22/2024
|
Merit Medical Launches basixSKY™ Inflation Device
- Versatile analog device offers fast inflation and ease of use, streamlining patient care Versatile analog device offers fast inflation and ease of use, streamlining patient care
- 05/21/2024
|
Merit Medical Shareholders Elect Silvia M. Perez as New Director
- Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit's Board of Directors Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit's Board of Directors
- 05/16/2024
|
Merit Medical Executive Leadership Team Update
- Joe Wright Appointed President Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program SOUTH JORDAN, Utah, May 15, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the appointment of Joe Wright as President, effective immediately. As President, Mr.
- 05/15/2024
|
Merit Medical (MMSI) to Expand Product Suite Via New Launch
- Merit Medical's (MMSI) latest additions to its embolotherapy portfolio are likely to improve the patient experience.
- 05/15/2024
|
Merit Medical Expands Embolics Portfolio with New Siege™ Vascular Plug and Bearing nsPVA Express™ Prefilled Syringe
- SOUTH JORDAN, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced US Food and Drug Administration (FDA) 510(k) clearance for its Siege Vascular Plug. Merit also announced the launch of its Bearing nsPVA Express Prefilled Syringe in the United States and Australia.
- 05/14/2024
|
Merit Medical (MMSI) Q1 Earnings Top Estimates, Margins Up
- Merit Medical (MMSI) benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter.
- 05/01/2024
|
Merit Medical Systems, Inc. (MMSI) Q1 2024 Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q1 2024 Earnings Conference Call April 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman, and CEO Brian Lloyd - CLO and Corporate Secretary Joe Wright - CCO Raul Parra - CFO Conference Call Participants Craig Bijou - Bank of America Securities Jason Bednar - Piper Sandler Jason Bedford - Raymond James Steve Lichtman - Oppenheimer Michael Petusky - Barrington Research Jim Sidoti - Sidoti & Company Mike Matson - Needham & Company John Young - Canaccord Operator Ladies and gentlemen, thank you for standing by. Welcome to the MMSI First Quarter 2024 Earnings Call.
- 04/30/2024
|
Merit Medical (MMSI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
- The headline numbers for Merit Medical (MMSI) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 04/30/2024
|
Merit Medical (MMSI) Beats Q1 Earnings and Revenue Estimates
- Merit Medical (MMSI) came out with quarterly earnings of $0.77 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.64 per share a year ago.
- 04/30/2024
|
Merit Medical Reports Results for First Quarter Ended March 31, 2024
- * Constant currency revenue; constant currency revenue, organic; non-GAAP gross profit and margin; non-GAAP operating income and margin; non-GAAP net income; non-GAAP EPS; and free cash flow are non-GAAP financial measures. A reconciliation of these financial measures to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.
- 04/30/2024
|
Merit Medical (MMSI) Earnings Expected to Grow: Should You Buy?
- Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/23/2024
|
BDX or MMSI: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
- 04/19/2024
|
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 04/10/2024
|
BDX vs. MMSI: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
- 04/03/2024
|
Here's Why Merit Medical (MMSI) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 03/27/2024
|
Merit Medical (MMSI) Launches FDA-Cleared Micro-Access System
- Merit Medical (MMSI) announces the launch of its latest FDA-approved Micro ACE Advanced Micro-Access System, which is likely to benefit interventional treatments using micro access.
- 03/20/2024
|
Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
- Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases
- 03/19/2024
|
Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
- SOUTH JORDAN, Utah, March 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2024, after the close of the stock market on Tuesday, April 30, 2024.
- 03/18/2024
|
Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 03/08/2024
|
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 03/07/2024
|
Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
- Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320 Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320
- 03/05/2024
|
Merit Medical (MMSI) Q4 Earnings Top Estimates, Gross Margin Up
- Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the fourth quarter.
- 02/29/2024
|
Merit Medical Systems, Inc. (MMSI) Q4 2023 Earnings Call Transcript
- Merit Medical Systems, Inc. (MMSI) Q4 2023 Earnings Call Transcript
- 02/28/2024
|
Compared to Estimates, Merit Medical (MMSI) Q4 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/28/2024
|
Merit Medical (MMSI) Q4 Earnings and Revenues Surpass Estimates
- Merit Medical (MMSI) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.79 per share a year ago.
- 02/28/2024
|
Stay Ahead of the Game With Merit Medical (MMSI) Q4 Earnings: Wall Street's Insights on Key Metrics
- Besides Wall Street's top -and-bottom-line estimates for Merit Medical (MMSI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
- 02/23/2024
|
Merit Medical (MMSI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Merit Medical (MMSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/21/2024
|
Merit Medical's (MMSI) SCOUT Guidance System Gets FDA Nod
- Merit Medical's (MMSI) SCOUT MD Surgical Guidance System receives FDA clearance, which aims to boost the treatment of breast cancer by increasing accuracy to target tumor sites.
- 02/19/2024
|
MMSI vs. ALGN: Which Stock Is the Better Value Option?
- Investors interested in Medical - Dental Supplies stocks are likely familiar with Merit Medical (MMSI) and Align Technology (ALGN). But which of these two stocks presents investors with the better value opportunity right now?
- 02/09/2024
|
Why Merit Medical (MMSI) Could Beat Earnings Estimates Again
- Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/31/2024
|
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 01/31/2024
|
Should You Buy Merit Medical (MMSI) After Golden Cross?
- Merit Medical Systems, Inc. (MMSI) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MMSI's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
- 01/30/2024
|
Reasons to Add Merit Medical (MMSI) to Your Portfolio Now
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 01/23/2024
|
MMSI or WST: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Merit Medical (MMSI) and West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?
- 12/28/2023
|
Why You Should Retain Merit Medical (MMSI) Stock for Now
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 12/11/2023
|
PDCO or MMSI: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Patterson Cos. (PDCO) or Merit Medical (MMSI).
- 11/16/2023
|
Merit Medical Caught Up In The Med-Tech Downswing
- Merit Medical delivered another quarter ahead of expectations, with strong growth in peripheral intervention, OEM manufacturing, and endoscopy, driving 7% organic revenue growth coupled with opex leverage. Assets acquired from AngioDynamics are already outperforming initial expectations, and performance in several peripheral and cardiac markets suggests share gains. The pivotal study for the Wrapsody endovascular graft is complete and Merit should be in a position to launch the product before the end of 2024.
- 10/31/2023
|
PDCO vs. MMSI: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Patterson Cos. (PDCO) or Merit Medical (MMSI).
- 10/31/2023
|
Merit Medical (MMSI) Q3 Earnings Top Estimates, FY23 View Revised
- Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the third quarter.
- 10/27/2023
|
Merit Medical Systems, Inc. (MMSI) Q3 2023 Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2023 Earnings Conference Call October 26, 2023 5:00 PM ET Company Participants Fred Lampropoulos – Founder, Chairman and Chief Executive Officer Brian Lloyd – Chief Legal Officer and Corporate Secretary Raul Parra – Chief Financial Officer and Treasurer Conference Call Participants Michael Petusky – Barrington Research Steve Lichtman – Oppenheimer & Co Jayson Bedford – Raymond James Zachary Day – Canaccord Genuity Jim Sidoti – Sidoti & Co Mike Matson – Needham and Company Operator Welcome to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Merit Medical Systems, Inc. At this time, all participants have been placed in listen-only mode. After the speakers' presentation, there will be a question-and-answer session.
- 10/26/2023
|
Merit Medical (MMSI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
- Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 10/26/2023
|
Merit Medical (MMSI) Beats Q3 Earnings and Revenue Estimates
- Merit Medical (MMSI) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.64 per share a year ago.
- 10/26/2023
|
Merit Medical's (MMSI) New Launch to Expand Its Product Suite
- Merit Medical's (MMSI) latest addition to its Vascular portfolio is expected to significantly improve patient outcomes.
- 10/12/2023
|
HSIC vs. MMSI: Which Stock Is the Better Value Option?
- Investors interested in Medical - Dental Supplies stocks are likely familiar with Henry Schein (HSIC) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
- 10/10/2023
|
3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 10/05/2023
|
Merit Medical Systems to Announce Third Quarter 2023 Results on October 26, 2023
- SOUTH JORDAN, Utah, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2023, after the close of the stock market on Thursday, October 26, 2023.
- 10/05/2023
|
Merit Medical's (MMSI) Aspira Bottle to Boost At-Home Services
- Merit Medical (MMSI) launches Aspira Bottle, complementing its Aspira Drainage System, that can provide compassionate home treatment option for critical cancer and other patients.
- 09/07/2023
|
Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 08/30/2023
|
PDCO or MMSI: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Patterson Cos. (PDCO) and Merit Medical (MMSI).
- 08/15/2023
|
Merit Medical (MMSI) Completes Enrollment in WRAPSODY Study
- Merit Medical (MMSI) is evaluating its device for treating stenosis/occlusion, WRAPSODY, in a pivotal study on patients undergoing hemodialysis. Primary data from the study is expected after six months.
- 08/10/2023
|
Merit Medical Systems, Inc. (MMSI) Q2 2023 Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q2 2023 Earnings Conference Call July 25, 2023 5:00 AM ET Company Participants Fred Lampropoulos - Chairman and Chief Executive Officer Raul Parra - Chief Financial Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Conference Call Participants Steve Lichtman - Oppenheimer & Company Jayson Bedford - Raymond James Larry Biegelsen - Wells Fargo Jason Bednar - Piper Sandler Mike Matson - Needham & Company Jim Sidoti - Sidoti & Company Michael Petusky - Barrington Research Operator Welcome to the Second Quarter of Fiscal Year 2023 Earnings Conference Call for Merit Medical Systems, Inc. [Operator Instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly. I would now like to turn the call over to Mr.
- 07/26/2023
|
Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 07/25/2023
|
Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates
- Merit Medical (MMSI) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.73 per share a year ago.
- 07/25/2023
|
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
- Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
- 07/13/2023
|
PDCO or MMSI: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Patterson Cos. (PDCO) and Merit Medical (MMSI).
- 07/11/2023
|
3 Top Healthcare Stocks to Buy for July
- Patterson Companies and Medtronic have above-average dividends. Merit Medical Systems and Medtronic have been active in growing revenue through acquisitions.
- 07/07/2023
|
Merit Medical Systems to Announce Second Quarter 2023 Results On July 25, 2023
- SOUTH JORDAN, Utah, July 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2023, after the close of the stock market on Tuesday, July 25, 2023.
- 07/06/2023
|
PDCO vs. MMSI: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Patterson Cos. (PDCO) or Merit Medical (MMSI).
- 06/22/2023
|
Merit Medical (MMSI) Expands Suite via Buyouts, Revises FY23 View
- Merit Medical's (MMSI) latest addition to its portfolio is expected to significantly enhance patient outcomes.
- 06/13/2023
|
3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- 05/23/2023
|
Merit Medical: To Unlock Further Risk Capital In FY 2023
- Merit Medical brought in another strong quarter from top-bottom lines for Q1 FY'23. The firm continues adding value for shareholders, throwing off piles of cash in doing so.
- 05/16/2023
|
Merit Medical (MMSI) Tops Q1 Earnings Estimates, Ups FY23 View
- Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the first quarter.
- 04/28/2023
|
Merit Medical (MMSI) is a Great Momentum Stock: Should You Buy?
- Does Merit Medical (MMSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 04/28/2023
|
Merit Medical Systems, Inc. (MMSI) Hits Fresh High: Is There Still Room to Run?
- Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 04/28/2023
|
Merit Medical Systems, Inc. (MMSI) Q1 2023 Earnings Call Transcript
- Merit Medical Systems, Inc. (MMSI) Q1 2023 Earnings Call Transcript.
- 04/26/2023
|
Compared to Estimates, Merit Medical (MMSI) Q1 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 04/26/2023
|
3 Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- 04/18/2023
|
HSIC or MMSI: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Henry Schein (HSIC) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
- 04/17/2023
|
Merit Medical (MMSI) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.
- 04/14/2023
|
Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
- SOUTH JORDAN, Utah, April 06, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2023, after the close of the stock market on Wednesday, April 26, 2023.
- 04/06/2023
|
Merit Medical's (MMSI) New Launch to Boost its Product Suite
- Merit Medical's (MMSI) latest addition to its Vascular portfolio is expected to significantly enhance patient outcomes.
- 03/21/2023
|
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- 03/15/2023
|
Merit Medical: Reasonably-Priced Execution, With M&A Upside
- Merit Medical delivered a modestly better than expected fourth quarter, with a little upside on revenue and a $0.02/share beat at the operating income line. Procedure normalization in areas like cardiology and electrophysiology should pull Merit along toward improved volumes in 2023.
- 02/25/2023
|
MMSI vs. WST: Which Stock Is the Better Value Option?
- MMSI vs. WST: Which Stock Is the Better Value Option?
- 02/23/2023
|
Merit Medical (MMSI) Q4 Earnings Top Estimates, Margins Down
- Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in its Cardiovascular segment and the majority of product categories within its Cardiovascular unit.
- 02/23/2023
|
Merit Medical Systems, Inc. (MMSI) Q4 2022 Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Raul Parra - Chief Financial Officer & Treasurer Conference Call Participants Steve Lichtman - Oppenheimer Jayson Bedford - Raymond James Mike Matson - Needham & Company Jim Sidoti - Sidoti & Company Lawrence Biegelsen - Wells Fargo Michael Petusky - Barrington Research Jason Bednar - Piper Sandler William Plovanic - Canaccord Genuity Operator Welcome to the Fourth Quarter of Fiscal Year 2022 Earnings Conference Call for Merit Medical Systems, Inc. At this time all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.
- 02/22/2023
|
Merit Medical (MMSI) Q4 Earnings and Revenues Surpass Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 17.91% and 1.26%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/22/2023
|
Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
- SOUTH JORDAN, Utah, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2022, and issue fiscal year 2023 guidance after the close of the stock market on Wednesday, February 22, 2023.
- 02/03/2023
|
5 Dental Supplies Stocks to Buy Amid Recovering Prospects
- Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.
- 02/03/2023
|
MMSI or ALGN: Which Is the Better Value Stock Right Now?
- MMSI vs. ALGN: Which Stock Is the Better Value Option?
- 01/25/2023
|
Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio
- Investors continue to be optimistic about Merit Medical (MMSI), owing to its strong product portfolio.
- 01/18/2023
|
MMSI vs. ALGN: Which Stock Is the Better Value Option?
- MMSI vs. ALGN: Which Stock Is the Better Value Option?
- 01/06/2023
|
MMSI vs. ALGN: Which Stock Is the Better Value Option?
- MMSI vs. ALGN: Which Stock Is the Better Value Option?
- 12/20/2022
|
Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- 12/15/2022
|
Merit Medical (MMSI) Hits 52-Week High: What's Driving It?
- Investors are optimistic about Merit Medical's (MMSI) slew of product launches.
- 12/05/2022
|
Merit Medical: Re-Rate To Buy, Upside Potential On Offer
- A Reversal in growth trends across the portfolio, leading to upsides vs. consensus at the top and bottom lines. Strong EPS upside growth forecasted by management into the coming quarters.
- 12/02/2022
|
Medical Devices Stock Pumps Up Buy Point With New Innovations
- After launching three new products and posting a second quarter of rising EPS growth, medical devices leader Merit Medical Systems is probing a new buy point. The post Medical Devices Stock Pumps Up Buy Point With New Innovations appeared first on Investor's Business Daily.
- 11/17/2022
|
Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- 11/17/2022
|
MMSI vs. CNMD: Which Stock Should Value Investors Buy Now?
- MMSI vs. CNMD: Which Stock Is the Better Value Option?
- 11/14/2022
|
Merit Medical (MMSI) Q3 Earnings Beat, FY22 View Revised
- Merit Medical (MMSI), in the third quarter, benefits from revenue growth in both its segments and the majority of product categories within its Cardiovascular unit.
- 10/27/2022
|
Merit Medical Systems, Inc. (MMSI) Fred Lampropoulos on Q3 2022 Results - Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2022 Earnings Conference Call October 26, 2022 5:00 PM ET Company Participants Fred Lampropoulos - President & CEO Brian Lloyd - Chief Legal Officer & Corporate Secretary Raul Parra - CFO Conference Call Participants Jayson Bedford - Raymond James Larry Biegelsen - Wells Fargo Mike Matson - Needham & Company William Plovanic - Canaccord Genuity Jason Bednar - Piper Sandler Jim Sidoti - Sidoti & Company Michael Petuski - Barrington Research Operator Good day and thank you for standing by. Welcome to the Merit Medical Systems Third Quarter 2022 Earnings Conference Call.
- 10/26/2022
|
Merit Medical (MMSI) Q3 Earnings and Revenues Top Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 20.75% and 5.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 10/26/2022
|
Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- 10/14/2022
|
Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
- SOUTH JORDAN, Utah, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2022, after the close of the stock market on Wednesday, October 26, 2022.
- 10/13/2022
|
Merit Medical (MMSI) Launches New Soft Tissue Biopsy System
- Merit Medical's (MMSI) launch of the TEMNO Elite Soft Tissue Biopsy System will boost its portfolio of biopsy devices.
- 09/29/2022
|
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
- Merit Medical's (MMSI) latest addition to its portfolio is expected to ease access to difficult anatomy in the peripheral vasculature, thereby serving a wider patient pool.
- 09/13/2022
|
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q2 2022 Results - Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q2 2022 Earnings Conference Call July 27, 2022 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Raul Parra - Chief Financial Officer & Treasurer Conference Call Participants Operator Welcome to the Second Quarter of Fiscal Year 2022 Earnings Conference Call for Merit Medical Systems, Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.
- 07/28/2022
|
Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
- SOUTH JORDAN, Utah, July 14, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2022, after the close of the stock market on Wednesday, July 27, 2022.
- 07/14/2022
|
Merit Medical's (MMSI) New Launch to Improve Patient Outcome
- Merit Medical's (MMSI) latest launch will likely aid in precisely targeting affected tissues, thereby resulting in more successful surgeries and improved patient outcomes.
- 07/11/2022
|
Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- 07/11/2022
|
Here's Why Merit Medical (MMSI) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 06/23/2022
|
Merit Medical (MMSI) is a Top-Ranked Value Stock: Should You Buy?
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 05/27/2022
|
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q1 2022 Results - Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q1 2022 Earnings Conference Call April 27, 2022 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman and Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Raul Parra - Chief Financial Officer and Treasurer Joseph Wright - Chief Commercial Officer Conference Call Participants Jayson Bedford - Raymond James Larry Biegelsen - Wells Fargo Mike Matson - Needham Jim Sidoti - Sidoti Steven Lichtman - Oppenheimer William Plovanic - Canaccord Operator Welcome to the First Quarter of Fiscal Year 2022 Earnings Conference Call for Merit Medical Systems, Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.
- 04/27/2022
|
Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 12.77% and 4.54%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 04/27/2022
|
Merit Medical (MMSI) Expected to Beat Earnings Estimates: Should You Buy?
- Merit Medical (MMSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/20/2022
|
Merit Medical's (MMSI) Latest Launch to Boost Patient Outcome
- Merit Medical's (MMSI) latest well-designed tray is expected to simplify the thoracostomy procedure and reduce treatment time, especially in critical situations.
- 04/19/2022
|
Merit Medical Systems to Announce First Quarter Results on April 27, 2022
- SOUTH JORDAN, Utah, April 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended March 31, 2022, after the close of the stock market on Wednesday, April 27, 2022.
- 04/13/2022
|
Merit Medical's (MMSI) SCOUT Bx Delivery System Gets FDA Nod
- Merit Medical's (MMSI) receipt of FDA clearance for the SCOUT Bx system can streamline treatment for cancer patients.
- 04/12/2022
|
Here's Why You Should Retain Merit Medical (MMSI) Stock For Now
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- 04/05/2022
|
Merit Medical's Underperformance Seems Overdone As Elective Procedures Normalize
- Merit Medical has been posting healthy revenue growth and should see a pickup in oncology and cardiology procedures as hospitals work through their elective procedure backlogs.
- 03/23/2022
|
Merit Medical's (MMSI) Q4 Earnings, Revenues Top Estimates
- Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in both its segments, and from majority of the product categories within its Cardiovascular unit.
- 02/28/2022
|
Merit Medical Systems' (MMSI) CEO Fred Lampropoulos on Q4 2021 Results - Earnings Call Transcript
- Merit Medical Systems' (MMSI) CEO Fred Lampropoulos on Q4 2021 Results - Earnings Call Transcript
- 02/26/2022
|
Merit Medical (MMSI) Beats Q4 Earnings and Revenue Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 42% and 3.17%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/24/2022
|
Here's Why You Should Retain Merit Medical (MMSI) Stock For Now
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its progress in the WAVE study and a strong product portfolio.
- 02/02/2022
|
Domino's, Bath & Body Works, among stocks that are oversold, says Chris Senyek
- Chris Senyek, Wolfe Research chief investment strategist, joins 'Power Lunch' to discuss which stocks have been oversold and those investors should watch.
- 01/21/2022
|
Merit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022
- SOUTH JORDAN, Utah, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2021, and issue FY 2022 guidance after the close of the stock market on Thursday, February 24, 2022.
- 01/17/2022
|
Here's Why You Should Retain Merit Medical (MMSI) Stock For Now
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.
- 12/23/2021
|
Merit Medical (MMSI) is a Top-Ranked Value Stock: Should You Buy?
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 11/09/2021
|
Merit Medical's (MMSI) Q3 Earnings, Revenues Top Estimates
- Merit Medical (MMSI), in the third quarter, benefits from revenue growth in its Cardiovascular segment, and from the majority of the product categories within its Cardiovascular unit.
- 10/29/2021
|
Merit Medical Systems, Inc (MMSI) CEO Fred Lampropoulos on Q3 2021 Results - Earnings Call Transcript
- Merit Medical Systems, Inc (MMSI) CEO Fred Lampropoulos on Q3 2021 Results - Earnings Call Transcript
- 10/28/2021
|
Merit Medical (MMSI) Surpasses Q3 Earnings and Revenue Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 18.18% and 2.36%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 10/28/2021
|
Here's Why You Should Retain Merit Medical (MMSI) Stock For Now
- Investors continue to be optimistic about Merit Medical (MMSI) owing to its potential in the Peripheral Intervention arm and a strong product portfolio.
- 10/06/2021
|
Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
- SOUTH JORDAN, Utah, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended September 30, 2021, after the close of the stock market on Thursday, October 28, 2021.
- 10/05/2021
|
3 Promising MedTech Stocks to Snap Up in Second-Half 2021
- Backed by robust long-term prospects, investors can add three lucrative MedTech stocks, MMSI, ITGR and OFIX, to their watchlist.
- 09/23/2021
|
Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
- Prospective, observational study published in CardioVascular and Interventional Radiology 1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a 12-month TLPP rate of 84.6% and a 12-month access circuit primary patency (“ACPP”) rate of 65.9%.
- 09/20/2021
|
3 Dental Stocks Poised to Perform Well in Second-Half 2021
- Let's keep a watch on three lucrative stocks, WST, HSIC and MMSI, in the dental space that investors can add to their watchlist backed by robust long-term prospects.
- 09/16/2021
|
Merit Medical (MMSI) Soars to 52-Week High, Time to Cash Out?
- Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 08/30/2021
|
Merit Medical (MMSI) Expands Drainage Portfolio With New Product
- Merit Medical's (MMSI) new commercial product launch can make sample collection simple, safe and efficient.
- 08/18/2021
|
Merit Medical Launches One-Vac™ Evacuated Drainage Bottle for Percutaneous Fluid Collection and Discard
- Advanced design makes sample collection simple, efficient, and safe Advanced design makes sample collection simple, efficient, and safe
- 08/16/2021
|
Merit Medical (MMSI) is a Great Momentum Stock: Should You Buy?
- Does Merit Medical (MMSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 08/05/2021
|
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q2 2021 Results - Earnings Call Transcript
- Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q2 2021 Results - Earnings Call Transcript
- 07/31/2021
|
Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 40.91% and 11.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/29/2021
|
Merit Medical Reports Results for Quarter Ended June 30, 2021
- * Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non-GAAP financial measures. A reconciliation of these financial measures to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.
- 07/29/2021
|
Here's Why You Should Retain Merit Medical (MMSI) Stock Now
- Merit Medical (MMSI) continues to gain traction from robust Peripheral Intervention arm and solid international presence. Forex, although, remains a concern.
- 07/12/2021
|
Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
- SOUTH JORDAN, Utah, July 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended June 30, 2021, after the close of the stock market on Thursday, July 29, 2021.
- 07/09/2021
|
Cardiology Space Gains Momentum in 2021: 5 Stocks to Focus on
- These cardiology device stocks Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), Merit Medical (MMSI), BD (BDX) are expected to continue their run over the next few months.
- 06/18/2021
|
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
- Investors continue to be optimistic about Merit Medical (MMSI), owing to its potential in the Peripheral Intervention arm and strong international foothold.
- 05/24/2021
|
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q1 2021 Results - Earnings Call Transcript
- Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q1 2021 Results - Earnings Call Transcript
- 04/30/2021
|
Merit Medical (MMSI) Q1 Earnings and Revenues Beat Estimates
- Merit Medical (MMSI) benefits from growth in revenues at the Cardiovascular segment in Q1.
- 04/30/2021
|
Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 40.54% and 7.73%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 04/29/2021
|
Merit Medical Systems: Q1 Earnings Insights
- Shares of Merit Medical Systems (NASDAQ:MMSI) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 36.84% year over year to $0.52, which beat the estimate of $0.36.
- 04/29/2021
|
Merit Medical Reports Results for Quarter Ended March 31, 2021
- * Constant currency revenue; constant currency revenue, organic; core revenue; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross margin; and free cash flow are non-GAAP financial measures. A reconciliation of these and other non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.
- 04/29/2021
|
Merit Medical Systems Earnings Preview
- Merit Medical Systems (NASDAQ:MMSI) releases its next round of earnings this Thursday, April 29. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.
- 04/28/2021
|
Dental Market Shows Strength Despite Pandemic: 3 Stocks to Watch
- Let's keep a watch on three lucrative stocks, XRAY, MCK and MMSI, in the dental space that have performed impressively despite the pandemic-led volatility.
- 04/15/2021
|
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Merit Medical Systems, Inc. (MMSI) on Behalf of Investors
- LOS ANGELES--(BUSINESS WIRE)---- $MMSI #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announces that it has commenced an investigation of potential claims against the board of directors of Merit Medical Systems, Inc. (“Merit Medical” or the “Company) (NASDAQ: MMSI) concerning whether the board of directors breached its fiduciary duties to Merit Medical shareholders. If you still hold Merit Medical shares purchased before February 2019 and wish to discuss t
- 04/13/2021
|
INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Merit Medical Systems, Inc.
- NEW YORK--(BUSINESS WIRE)---- $MMSI--The law firm of Kirby McInerney LLP is investigating claims against Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI). The investigation focuses on whether the Company's board of directors has breached its fiduciary duties to the Company. If you purchased or otherwise acquired Merit Medical securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by
- 04/12/2021
|
SHAREHOLDER ALERT: Merit Medical Systems, Inc. (MMSI) Officers and Directors Under Investigation for False Statements and Insider Trading
- SAN FRANCISCO, April 12, 2021 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Merit Medical Systems, Inc. (NASDAQ: MMSI) relating to possible false statements to investors and insider trading by officers and directors. A securities class action against the company in the United States District Court for the Central District of California recently survived a motion to dismiss allegations that between February 26 and October 30, 2019, Merit and its CEO and CFO made false and misleading statements about the company's integration of Cianna and ClariVein, two highly-touted corporate acquisitions.
- 04/12/2021
|
INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Merit Medical Systems, Inc.
- NEW YORK--(BUSINESS WIRE)---- $MMSI--The law firm of Kirby McInerney LLP is investigating claims against Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI). The investigation focuses on whether the Company's board of directors has breached its fiduciary duties to the Company. If you purchased or otherwise acquired Merit Medical securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by
- 04/09/2021
|
Merit Medical Systems to Announce First Quarter Results on April 29, 2021
- SOUTH JORDAN, Utah, April 09, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the first quarter ended March 31, 2021, after the close of the stock market on Thursday, April 29, 2021.
- 04/09/2021
|
Merit Medical to Present at 20th Annual Needham Healthcare Conference
- SOUTH JORDAN, Utah, April 08, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference.
- 04/08/2021
|
EQUITY ALERT: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by Management of Merit Medical Systems, Inc. – MMSI
- NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by management of Merit Medical Systems, Inc. (NASDAQ: MMSI) resulting from allegations that management may have issued materially misleading business information to the investing public. If you currently own shares of Merit Medical, please visit the firm's website at https://www.rosenlegal.com/cases-register-2066.html for more information. You may al
- 03/26/2021
|
First Patients Enrolled in the Merit WRAPSODY AV Access Efficacy Pivotal Study
- U.S. pivotal study to determine safety and effectiveness of the WRAPSODY Endovascular Stent Graft System in the treatment of dialysis outflow circuit stenosis or occlusion U.S. pivotal study to determine safety and effectiveness of the WRAPSODY Endovascular Stent Graft System in the treatment of dialysis outflow circuit stenosis or occlusion
- 03/11/2021
|
Merit Medical (MMSI) Q4 Earnings and Revenues Beat Estimates
- Merit Medical (MMSI) benefits from growth in revenues at the Cardiovascular segment in Q4.
- 02/25/2021
|
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q4 2020 Results - Earnings Call Transcript
- Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q4 2020 Results - Earnings Call Transcript
- 02/24/2021
|
Merit Medical (MMSI) Q4 Earnings and Revenues Surpass Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 25.58% and 3.05%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/24/2021
|
Merit Medical Systems: Q4 Earnings Insights
- Shares of Merit Medical Systems (NASDAQ:MMSI) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 35.00% year over year to $0.54, which beat the estimate of $0.43.
- 02/24/2021
|
Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2020, Issues FY 2021 Guidance
- * Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A reconciliation of these and other non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.
- 02/24/2021
|
Merit Medical (MMSI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/17/2021
|
Merit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021
- SOUTH JORDAN, Utah, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2020, after the close of the stock market on Wednesday, February 24, 2021.
- 02/12/2021
|
Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference
- SOUTH JORDAN, Utah, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in an upcoming investor conference.
- 02/10/2021
|
Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio
- Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.
- 01/11/2021
|
Merit Medical to Participate in Two Upcoming Investor Conferences
- SOUTH JORDAN, Utah, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in two upcoming investor conferences.
- 01/07/2021
|
Merit Medical Systems (MMSI) Sees Hammer Chart Pattern: Time to Buy?
- Merit Medical Systems (MMSI) has been struggling lately, but the selling pressure may be coming to an end soon.
- 01/05/2021
|
Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio
- Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.
- 12/28/2020
|
Merit Medical to Present “Foundations for Growth” Program and Financial Targets for 2020 to 2023
- SOUTH JORDAN, Utah, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, will hold an investor call today to introduce its multi-year financial targets for growth and improved profitability and will host a question-and-answer session.
- 11/10/2020
|
Merit Medical Systems Stock Is Up 2x But Has More To Go
- Despite a solid 2x rise since the March 23 lows of this year, at the current price of around $50 per share we believe Merit Medical Systems stock, a company that manufactures disposable medical devices and surgical kits, has more room for growth in the near term. MMSI stock has rallied from $26.
- 11/05/2020
|
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q3 2020 Results - Earnings Call Transcript
- Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q3 2020 Results - Earnings Call Transcript
- 10/29/2020
|
Merit Medical (MMSI) Q3 Earnings and Revenues Beat Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 121.05% and 11.38%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
- 10/28/2020
|
Merit Medical Reports Results for Third Quarter; Issues Updated 2020 Guidance
- * Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A reconciliation of these and other non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.
- 10/28/2020
|
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
- Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
- 08/19/2020
|
The Daily Biotech Pulse: Poseida's Phase 1 Study Placed On Clinical Hold, Orphan Drug Designation For Krystal Biotech, Tiziana's Patent Award
- Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
Catalent Inc (NYSE: CTLT)
CureVac N.V. (NASDAQ: CVAC) (follow-on buying after a 250% advance on its debut Friday...
- 08/18/2020
|
Stocks To Watch: Walmart, Target, Kandi And Gold vs. Bitcoin
- Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
- 08/15/2020
|
MMSI or ALGN: Which Is the Better Value Stock Right Now?
- MMSI vs. ALGN: Which Stock Is the Better Value Option?
- 08/11/2020
|
Enteral Stents Market Forecast Model 2020-2030 (COVID-19 Impact) - ResearchAndMarkets.com
|
Merit Medical to Participate at Canaccord Genuity and Needham Conferences
- SOUTH JORDAN, Utah, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will present at the Canaccord Genuity 40th Annual Growth Conference and participate in the 5th Annual Needham Virtual Med Tech 1x1 Conference. On Thursday, August 13th, at 8:30 a.m. ET, Merit’s Chairman and Chief Executive Officer Fred P. Lampropoulos and Chief Financial Officer Raul Parra will deliver a virtual presentation at the Canaccord Genuity 40th Annual Growth Conference and will also be participating in one-on-one virtual meetings that day.On Monday, August 17th, Messrs. Lampropoulos and Parra will be participating in one-on-one virtual meetings at the 5th Annual Needham Virtual Med Tech 1x1 Conference.ABOUT MERITFounded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.CONTACTS: Judy Wagner Corporate Communications (801) 208-4793 (office) jwagner@merit.comPatrick McCarty Investor Relations (801) 208-4581 (office) patrick.mccarty@merit.com
- 08/06/2020
|
Is Now The Time To Look At Buying Merit Medical Systems, Inc. (NASDAQ:MMSI)?
- Merit Medical Systems, Inc. (NASDAQ:MMSI), is not the largest company out there, but it saw a decent share price...
- 08/04/2020
|
Merit Medical Systems (NASDAQ:MMSI) PT Raised to $51.00
- Merit Medical Systems (NASDAQ:MMSI) had its price target boosted by Raymond James from $49.00 to $51.00 in a research report sent to investors on Thursday, BenzingaRatingsTable reports. They currently have an outperform rating on the medical instruments supplier’s stock. Other equities research analysts also recently issued reports about the company. ValuEngine downgraded Merit Medical Systems […]
- 08/03/2020
|
Merit Medical Systems (NASDAQ:MMSI) Upgraded to Strong-Buy at BidaskClub
- BidaskClub upgraded shares of Merit Medical Systems (NASDAQ:MMSI) from a buy rating to a strong-buy rating in a research note released on Thursday, BidAskClub reports. Several other analysts have also recently weighed in on the company. ValuEngine cut Merit Medical Systems from a buy rating to a hold rating in a research report on Thursday, […]
- 08/03/2020
|
Advisor Group Holdings Inc. Purchases Shares of 1,887 Merit Medical Systems, Inc. (NASDAQ:MMSI)
- Advisor Group Holdings Inc. purchased a new stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,887 shares of the medical instruments supplier’s stock, valued at approximately $60,000. A number of other large investors […]
- 08/03/2020
|
Merit Medical Systems (NASDAQ:MMSI) Given New $54.00 Price Target at Barrington Research
- Merit Medical Systems (NASDAQ:MMSI) had its price target upped by Barrington Research from $49.00 to $54.00 in a research note released on Thursday morning, The Fly reports. Barrington Research currently has an outperform rating on the medical instruments supplier’s stock. A number of other research analysts also recently weighed in on the company. Sidoti raised […]
- 08/03/2020
|
The Daily Biotech Pulse: Sanofi-GSK Land $2.1B Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche
- Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 30)
Achieve Life Sciences Inc (NASDAQ: ACHV)
Annexon Inc (NASDAQ: ANNX) (IPOed July 24)
Atossa Therapeutics...
- 07/31/2020
|
Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates
- Merit Medical (MMSI) reported a drop in revenues at every key operating segment in Q2.
- 07/30/2020
|
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q2 2020 Results - Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2020 Earnings Conference Call July 29, 2020 5:00 PM ET Company Participants Fred Lampropoulos - Chief Executive Officer Brian Lloyd - Chief Legal Officer Raul Parra - Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Steve Lichtman - Oppenheimer Cecilia Furlong - Canaccord Mike Petusky - Barrington Research Jayson Bedford - Raymond James Jim Sidoti - Sidoti & Company Mike Matson - Needham & Company Matthew O'Brien - Piper Sandler Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Merit Medical Systems Second Quarter 2020 Earnings Call.
- 07/30/2020
|
Merit Medical Systems Inc (MMSI) Q2 2020 Earnings Call Transcript
- MMSI earnings call for the period ending June 30, 2020.
- 07/30/2020
|
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
- Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP)
Annexon...
- 07/30/2020
|
Merit Medical Reports Results for Quarter Ended June 30, 2020
- * Q2 2020 worldwide revenue of $218.4 million, down (14.5)% as reported compared to Q2 2019 * Q2 2020 core revenue on a constant currency basis* down (13.6)% compared to Q2 2019 * Q2 2020 GAAP loss per share was $(0.34), compared to GAAP EPS of $0.12 in Q2 2019 * Q2 2020 non-GAAP EPS* was $0.31, compared to $0.42 in Q2 2019 * Q2 2020 free cash flow* was $32 million, and $47 million YTD* Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A reconciliation of these and other non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.SOUTH JORDAN, Utah, July 29, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced revenue of $218.4 million for the quarter ended June 30, 2020, a decrease of (14.5)% compared to revenue of $255.5 million for the quarter ended June 30, 2019. Core revenue on a constant currency basis* for the second quarter of 2020 was down (13.6)% compared to revenue for the second quarter of 2019.Merit’s GAAP gross margin for the second quarter of 2020 was 38.6%, compared to GAAP gross margin of 43.8% for the second quarter of 2019. Merit’s non-GAAP gross margin* for the second quarter of 2020 was 44.7%, compared to non-GAAP gross margin* of 48.7% for the second quarter of 2019.Merit’s GAAP operating margin for the second quarter of 2020 was (8.7)%, compared to GAAP operating margin of 4.8% for the second quarter of 2019. Merit’s non-GAAP operating margin* for the second quarter of 2020 was 11.2%, compared to non-GAAP operating margin* of 13.3% for the second quarter of 2019.Merit’s GAAP net loss for the second quarter of 2020 was $(19.1) million, or $(0.34) per share, compared to GAAP net income of $6.9 million, or $0.12 per share, for the second quarter of 2019. Merit’s non-GAAP net income* for the quarter ended June 30, 2020 was $17.4 million, or $0.31 per share, compared to non-GAAP net income* of $23.8 million, or $0.42 per share, for the quarter ended June 30, 2019.Merit’s revenue by category for the three and six-month periods ended June 30, 2020, compared to the corresponding periods in 2019, was as follows (unaudited, in thousands, except for percentages): Three Months Ended June 30, Six Months Ended June 30, % Change 2020 2019 % Change 2020 2019 Cardiovascular Peripheral Intervention (18.2)% $ 72,635 $ 88,848 (7.9)% $ 159,710 $ 173,481 Cardiac Intervention (17.1)% 66,005 79,643 (8.9)% 138,596 152,183 Custom Procedural Solutions (4.0)% 45,319 47,216 (0.1)% 92,940 93,077 OEM (8.9)% 28,218 30,959 (3.3)% 56,475 58,405 Total (14.0)% 212,177 246,666 (6.2)% 447,721 477,146 Endoscopy Endoscopy devices (30.1)% 6,194 8,866 (15.3)% 14,175 16,735 Total (14.5)% $ 218,371 $ 255,532 (6.5)% $ 461,896 $ 493,881 “During the second quarter we continued to make progress on the goals we initiated in early 2019, including the movement of 14 product lines and consolidation of certain facilities,” said Fred P. Lampropoulos, Merit’s Chairman and CEO. “We are particularly pleased with the generation of free cash flow* of $32 million for the quarter and $47 million year to date.”“We also focused on dealing with the challenges of the COVID-19 pandemic,” Lampropoulos said. “Our priority was the safety of employees. Deemed an ‘essential provider,’ we continued operation in all of our facilities worldwide by implementing CDC recommendations, including temperature testing, social distancing, mask-wearing, frequent hand-washing and installing separation barriers.”“In order to balance the reduction of incoming sales orders due to the suspension of elective procedures by many facilities we serve, we reduced headcounts, implemented targeted furloughs, and reduced salaries for a number of groups, including all executive positions,” Lampropoulos said. “We also reduced the number of research and development projects to focus on the highest priority projects in order to reach our financial and competitive objectives.”“During the second quarter, we received the CE mark for the Merit WRAPSODY™ Endoprosthesis Stent System, and we have initiated commercialization in the European Union,” Lampropoulos continued. “We also received approval for the WRAPSODY Arterial Venous access Efficacy (WAVE) IDE trial from the FDA. This approval will allow us to proceed on several cohorts with up to 50 institutions and more than 350 patients, in anticipation of application for the FDA’s consideration of PMA approval for commercialization in the United States. We also introduced new products that address needs in the COVID-19 environment which have had an impact in the second quarter, which we believe will offer additional opportunities.”“We added three new directors with substantial medical device experience and have formed an Operating Committee to establish future financial and performance objectives that we plan to announce during our third quarter report in October,” Lampropoulos said.“As recently reported, we reached an agreement with the U.S. Department of Justice to fully resolve its pending investigation,” Lampropoulos said. “Based upon that agreement, we recorded a charge of approximately $18 million during the second quarter. We intend to release additional details regarding the settlement following the finalization of the settlement documents.”“With COVID-19 cases increasing, the pace of recovery of elective procedures is still uncertain,” Lampropoulos said. “Access to customers and opportunities to pursue clinical trials for new products are still very limited. However, we are still proceeding with new product development, clinical and regulatory activities, and marketing and training programs. Assuming eventual progress in the fight against the COVID-19 pandemic, we believe we are well positioned to provide new products and services as well as reliable supply of our existing products.”“In order to maintain various departments and prepare to meet the needs of our customers, we plan to reduce certain furloughs and provide guaranteed levels of income for some sales associates, which will add some expense in the third quarter,” Lampropoulos added.“As we enter the uncertainty of the third quarter, we maintain our guidance suspension for 2020 until we have more visibility into the future,” Lampropoulos continued. “We believe we have substantially balanced the inputs and outputs of revenues and costs, while we strive to maintain a healthy sales force. We anticipate that additional adjustments will be necessary as we navigate these uncharted waters. We remain positive about our prospects for growth and continued profitability as we move forward.”As of June 30, 2020, Merit had cash on hand of approximately $50 million and net borrowing capacity of approximately $183 million, which was undrawn as of June 30, 2020.2020 GUIDANCEDue to the general uncertainty and rapidly changing global environment related to the COVID-19 pandemic and corresponding economic downturn, Merit’s management has concluded that it cannot issue financial guidance for the remainder of 2020.CONFERENCE CALLMerit will hold its investor conference call (conference ID 6997109) today, Wednesday, July 29, 2020, at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). The domestic telephone number is (844) 578‑9672 and the international number is (508) 637‑5656. A live webcast and slide deck will also be available at merit.com.
- 07/29/2020
|
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
- Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 28)
Axonics Modulation Technologies Inc (NASDAQ: AXNX)
Capricor Therapeutics Inc (NASDAQ: CAPR)
Fulgent Genetics Inc...
- 07/29/2020
|
Merit Medical Systems Scores Relative Strength Rating Upgrade; Hits Key Benchmark
- Merit Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.
- 07/28/2020
|
Merit Medical Systems Trying To Close In On Key Technical Benchmark
- A Relative Strength Rating upgrade for Merit Medical Systems shows improving technical performance. Will it continue?
- 07/27/2020
|
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
- Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
- 07/26/2020
|
Earnings Preview: Merit Medical (MMSI) Q2 Earnings Expected to Decline
- Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/22/2020
|
State Street Corp Purchases 100,151 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)
- State Street Corp boosted its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,057,843 shares of the medical instruments supplier’s stock after purchasing an additional 100,151 shares during the quarter. State Street Corp’s […]
- 07/18/2020
|
Merit Medical Systems to Announce Second Quarter Results on July 29, 2020
- SOUTH JORDAN, Utah, July 17, 2020 -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in.
- 07/17/2020
|
Analysts Estimate Merit Medical (MMSI) to Report a Decline in Earnings: What to Look Out for
- Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/16/2020
|
Merit Medical (MMSI) Looks Good: Stock Adds 6.7% in Session
- Merit Medical (MMSI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
- 07/16/2020
|
Merit Medical Announces Agreement in Principle with Department of Justice
- SOUTH JORDAN, Utah, July 15, 2020 -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,.
- 07/15/2020
|
Here's Why You Should Retain Merit Medical (MMSI) for Now
- Investor confidence is high on Merit Medical (MMSI) stock, thanks to solid prospects.
- 07/15/2020
|
Here's Why You Should Retain Merit Medical (MMSI) for Now
- Stocks Analysis by Zacks Investment Research covering: Medtronic PLC, Cardinal Health Inc, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated. Read Zacks Investment Research's latest article on Investing.com
- 07/15/2020
|
State of Alaska Department of Revenue Purchases 990 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)
- State of Alaska Department of Revenue grew its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 1.9% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 52,238 shares of the medical instruments supplier’s stock after buying an additional 990 shares during the period. State of […]
- 07/12/2020
|
Do Hedge Funds Love Merit Medical Systems, Inc. (MMSI)?
- The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]
- 07/05/2020
|
Activist Campaigns Look for Second-Half Revival After Slow 2020 - BNN Bloomberg
- Shareholder activism is expected to bounce back in the second half of 2020 after many investors shied away from big boardroom battles in the first six months of the year as the coronavirus roiled markets.
- 07/01/2020
|
Surgical Scalpel Market 2020-2024 | Increase in Volume of Surgeries to Boost Growth | Technavio
- The Global Surgical Scalpel Market will grow by USD 105.29 mn during 2020-2024
- 07/01/2020
|
Oppenheimer Assigns a Buy Rating on Tandem Diabetes Care (TNDM) - Markets
- Oppenheimer analyst Steven Lichtman assigned a Buy rating to Tandem Diabetes Care (TNDM – Research Report) today and set a
- 06/30/2020
|
Intravenous Fluid Bags Market 2020-2024 | Rising Prevalence Of Chronic Diseases To Boost Growth | Technavio
- The Global Intravenous Fluid Bags Market will grow by $ 667.51 mn during 2020-2024
- 06/26/2020
|
Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Purchased by Geode Capital Management LLC
- Geode Capital Management LLC lifted its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 7.4% in the 1st quarter, HoldingsChannel.com reports. The firm owned 798,440 shares of the medical instruments supplier’s stock after acquiring an additional 55,320 shares during the quarter. Geode Capital Management LLC’s holdings in Merit Medical Systems were worth $24,951,000 as of […]
- 06/25/2020
|
Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (NASDAQ: HRTX) and Tandem Diabetes Care (NASDAQ: TNDM) - Markets
- There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Heron Therapeutics
- 06/22/2020
|
Victory Capital Management Inc. Sells 23,393 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)
- Victory Capital Management Inc. lessened its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 22.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 81,103 shares of the medical instruments supplier’s stock after selling 23,393 shares during the quarter. Victory Capital Management Inc. […]
- 06/22/2020
|
Parametric Portfolio Associates LLC Sells 1,144 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)
- Parametric Portfolio Associates LLC decreased its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 0.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 201,572 shares of the medical instruments supplier’s stock after selling 1,144 shares during the period. Parametric Portfolio Associates LLC owned […]
- 06/20/2020
|
The Global Catheter Securement Devices Market is expected to grow from USD 917.10 Million in 2019 to USD 1,243.87 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.21%
- Market Segmentation & Coverage: This research report categorizes the Catheter Securement Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
- 06/20/2020
|
Merit Medical Systems, Inc. (NASDAQ:MMSI) Position Trimmed by M&T Bank Corp
- M&T Bank Corp lessened its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 2.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,254 shares of the medical instruments supplier’s stock after selling 363 shares during the […]
- 06/18/2020
|
Catheter Market Size is Projected to Witness 8.8% CAGR in Near Future: P&S Intelligence
- Around the world, the volume of interventional radiology procedures is rising, on account of being less invasive than conventional, open medical procedures,
- 06/15/2020
|
First Trust Advisors LP Buys Shares of 7,781 Merit Medical Systems, Inc. (NASDAQ:MMSI)
- First Trust Advisors LP purchased a new position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 7,781 shares of the medical instruments supplier’s stock, valued at approximately $243,000. Several other institutional investors have also […]
- 06/10/2020
|
Commvault settles with Starboard, adds 3 newcomers to board
- By Svea Herbst-Bayliss and Munsif VengattilJune 8 (Reuters) - Data management software maker Commvault Systems Inc said on Monday it reached an agreement...
- 06/08/2020
|
Kaskela Law LLC Announces Investigation of Merit Medical Systems, Inc. (MMSI) and Encourages Long-Term MMSI Investors to Contact the Firm
- Kaskela Law LLC announces that it is investigating Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (Nasdaq: MMSI) on behalf of the Company's stockholders.
- 06/06/2020
|
Surgical Snare Market 2020 Share, Industry Trends, By Usability, Application, End-User, Size, Leading Players and Global Forecast to 2026
- Jun 06, 2020 (CDN Newswire via Comtex) --
Surgical Snare Market with COVID-19 impact analysis provides wholesome information about the market size, share,...
- 06/06/2020
|
Aspiration And Biopsy Needles Market Clinical Demand, Production, Key Players and Forecast till 2026 : CONMED Corporation, Medtronic Plc, Olympus, Becton Dickinson
- Jun 02, 2020 (Market Insight Reports) --
Latest Industry Research Report On global Aspiration And Biopsy NeedlesMarket Research Report 2020 in-depth analysis...
- 06/02/2020
|
Sidoti & Co. Maintains Buy on Merit Medical Systems, Raises Price Target to $63
|
L'attivista Starboard Value si concentra su un'azienda di dispositivi medici | Invezz
- Starboard Value, una società di investimento attivista di alto livello, ha accumulato una partecipazione del 9% in Merit Medical Systems, Inc. (NASDAQ: MMSI), un produttore di dispositivi medici monouso, secondo quanto riferito da CNBC. Chi sono Starboard e Merit Medical? Starboard vanta un’impressionante esperienza nello spingere le aziende a cambiare le loro operazioni. L’azienda ha esperienza in diversi segmenti di mercato che vanno dalla tecnologia, al cloud computing, alla ristorazione. L’investitore attivista controlla ora quasi 250 milioni di dollari di azioni del Merit Medical i cui prodotti sono utilizzati principalmente nelle procedure mediche interventistiche, diagnostiche e terapeutiche, secondo la CNBC.
- 05/31/2020
|
Proxy fights for board seats may look like 2013-2018 - ValueWalk
- Activists had won 224 board seats globally year-to-date in settlements as of Tuesday, before Starboard and Wynnefield further boosted
- 05/31/2020
|
El activista Starboard Value tiene como objetivo la compañía de dispositivos médicos | Invezz
- Starboard Value, una empresa inversionista activista de primer nivel, amasó un 9% de participación en Merit Medical Systems, Inc. (NASDAQ: MMSI), un fabricante de dispositivos médicos desechables, informó la CNBC. ¿Quién son Starboard y Merit Medical? Starboard cuenta con un impresionante historial de presionar a las empresas para que cambien sus operaciones. La firma tiene experiencia en múltiples segmentos de mercado que van desde la tecnología, la computación en nube y los restaurantes. El inversionista activista ahora controla cerca de $250 millones de dólares en acciones de Merit Medical, cuyos productos se utilizan principalmente en procedimientos médicos de intervención, diagnóstico
- 05/30/2020
|
Activist Starboard Value targets medical device company | Invezz
- Starboard Value, a top-tier activist investor firm, amassed a 9% stake in Merit Medical Systems, Inc. (NASDAQ: MMSI), a manufacturer of disposable medical devices, CNBC reported. Who is Starboard and Merit Medical? Starboard boasts an impressive track record of pushing companies to change their operations. The firm boasts expertise across multiple market segments ranging from technology, cloud computing, and restaurants. The activist investor now controls nearly $250 million worth of shares in Merit Medical whose products are used mostly in interventional, diagnostic, and therapeutic medical procedures, according to CNBC. Background Starboard and Merit Medical entered into an agreement on May
- 05/30/2020
|
Activist Starboard pushes for change at a medical device company that could be a takeover candidate
- A successful activist is gently pushing for change at Merit Medical Systems.
- 05/30/2020
|
Merit Medical Reaches Deal With Starboard Value
- Starboard will take three seats on the board of Merit Medical, a maker of disposable medical devices. Also, Ascendis Pharma and Spectrum Brands see big investors lower stakes.
- 05/30/2020
|
Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $49
|
Merit Medical Announces Agreement With Starboard, Nominates Three Independent Directors
|
Merit Medical Announces Agreement With Starboard
- Nominates Three Medical Device Industry Veterans – Lonny Carpenter, David Floyd and James Hogan – for Election to the Board of Directors Announces Formation of Operating.
- 05/26/2020
|
Merit Medical Receives CE Mark for Wrapsody™ Endovascular Stent Graft System
|
Merit Medical Receives CE Mark for Wrapsody™ Endovascular Stent Graft System
- The WRAPSODY system is a flexible self-expanding endoprosthesis indicated for use in hemodialysis patients for the treatment of stenosis or occlusion within central veins as well as the dialysis outflow circuit of an arteriovenous (AV) fistula or AV graft. Merit has worked for almost eight years to design, develop and establish the appropriate technology and manufacturing capabilities for this product. Merit recently completed enrollment and primary follow-up of its WRAPSODY FIRST study which included 46 patients in Europe.
- 05/26/2020
|
Merit Medical (MMSI) Up 18.4% Since Last Earnings Report: Can It Continue?
- Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 05/23/2020
|
Merit Medical (MMSI) Up 18.4% Since Last Earnings Report: Can It Continue?
|
Here's Why You Should Retain Merit Medical (MMSI) for Now
- Investor confidence is high in Merit Medical (MMSI) stock, thanks to solid prospects.
- 05/20/2020
|
Research Report with COVID-19 Forecasts-Surgical Scalpel Market 2020-2024 | Increase in Volume of Surgeries to Boost Growth | Technavio
- The surgical scalpel market size has the potential to grow by USD 105.29 million during 2020-2024
- 05/20/2020
|
NYSE:MMSI Investor Notice: Lawsuit against Merit Medical Systems, Inc. announced by Shareholders Foundation
- SAN DIEGO, CA / ACCESSWIRE / May 19, 2020 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in (NYSE:MMSI) shares. Investors, who purchased shares of Merit Medical ...
- 05/19/2020
|
Activist Starboard Builds New Stakes in ACI Worldwide, Resideo - BNN Bloomberg
- Activist investor Starboard Value built new positions in payments processor ACI Worldwide Inc. and Resideo Technologies Inc. during the first quarter.
- 05/15/2020
|
Starboard Value Takes Share Stake In Merit Medical Systems Of 4.8M Shares
|
Gastrointestinal Stents Market Insights, 2020-2025 by Product Type, Technology Type, Material, End-user and Region - ResearchAndMarkets.com
|
Intestinal Stents Market Size 2020: Covid-19 Impact Analysis Report By Market Worth, Segmentation and Cost Analysis, Price, Revenue and Gross profit with Forecast to 2025
- May 12, 2020 (The Expresswire) --
Final Report will add the analysis of the impact of COVID-19 on this industry The“Intestinal Stents Market”2020 report...
- 05/12/2020
|
Shareholder Alert: Robbins LLP Announces It Is Investigating Merit Medical Systems, Inc. (MMSI) for Misleading Shareholders
- Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics.
- 05/07/2020
|
Shareholder Alert: Robbins LLP Announces It Is Investigating Merit Medical Systems, Inc. (MMSI) for Misleading Shareholders
- Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Se
- 05/07/2020
|
Stryker (SYK) Gets a Hold Rating from Oppenheimer
- Oppenheimer analyst Steven Lichtman maintained a Hold rating on Stryker (SYK) today and set a price target of $200.00. The company's shares closed last
- 05/01/2020
|
Stryker (SYK) Gets a Hold Rating from Oppenheimer
- Oppenheimer analyst
Steven Lichtman
maintained a
Hold
rating on Stryker (
SYK
–
Research Report
) today and set a price target of
$200.00
. The company’s shares closed last Thursday at $186.43.
According to
TipRanks.com
, Lichtman is ranked 0 out of
- 05/01/2020
|
Analysts' Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
- There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (LMAT), Aerie Pharma (AERI) and BioLife
- 05/01/2020
|
Analysts’ Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
- There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (
LMAT
–
Research Report
), Aerie Pharma (
AERI
–
Research Report
) and BioLife Solutions (
BLFS
–
Research Report
) with bullish sentime
- 05/01/2020
|
Oppenheimer Assigns a Buy Rating on Tandem Diabetes Care (TNDM)
- In a report released today, Steven Lichtman from Oppenheimer assigned a Buy rating to Tandem Diabetes Care (TNDM), with a price target of $92.00. The
- 05/01/2020
|
Oppenheimer Assigns a Buy Rating on Tandem Diabetes Care (TNDM)
- In a report released today,
Steven Lichtman
from Oppenheimer assigned a
Buy
rating to Tandem Diabetes Care (
TNDM
–
Research Report
), with a price target of
$92.00
. The company’s shares closed last Thursday at $79.78.
According to
TipRanks.com
, Li
- 05/01/2020
|
Cryolife (CRY) Receives a Rating Update from a Top Analyst
- In a report released today, Jason Mills from Canaccord Genuity maintained a Hold rating on Cryolife (CRY), with a price target of $24.00. The company's
- 05/01/2020
|
Cryolife (CRY) Receives a Rating Update from a Top Analyst
- In a report released today, Jason Mills from Canaccord Genuity maintained a Hold rating on Cryolife (CRY – Research Report),
- 05/01/2020
|
Canaccord Genuity Reaffirms Their Hold Rating on Lemaitre Vascular (LMAT)
- Canaccord Genuity analyst Jason Mills maintained a Hold rating on Lemaitre Vascular (LMAT) yesterday and set a price target of $28.00. The company's
- 05/01/2020
|
Canaccord Genuity Reaffirms Their Hold Rating on Lemaitre Vascular (LMAT)
- Canaccord Genuity analyst Jason Mills maintained a Hold rating on Lemaitre Vascular (LMAT – Research Report) yesterday and set a
- 05/01/2020
|
Stocks To Watch: Merit Medical Systems Sees RS Rating Jump To 93
|
Raymond James Maintains a Buy Rating on Boston Scientific (BSX)
- In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Boston Scientific (BSX), with a price target of $43.00. The
- 04/30/2020
|
Raymond James Maintains a Buy Rating on Boston Scientific (BSX)
- In a report released today,
Jayson Bedford
from Raymond James maintained a
Buy
rating on Boston Scientific (
BSX
–
Research Report
), with a price target of
$43.00
. The company’s shares closed last Thursday at $36.84.
According to
TipRanks.com
, Bed
- 04/30/2020
|
SurModics (SRDX) Gets a Buy Rating from Barrington
- In a report released today, Michael Petusky from Barrington maintained a Buy rating on SurModics (SRDX), with a price target of $56.00. The company's
- 04/30/2020
|
SurModics (SRDX) Gets a Buy Rating from Barrington
- In a report released today,
Michael Petusky
from Barrington maintained a
Buy
rating on SurModics (
SRDX
–
Research Report
), with a price target of
$56.00
. The company’s shares closed last Wednesday at $38.39.
According to
TipRanks.com
, Petusky is
- 04/30/2020
|
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (TDOC), LivaNova (LIVN) and Theratechnologies (THTX)
- Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC), LivaNova (LIVN) and Theratechnologies (THTX). Teladoc
- 04/30/2020
|
Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (NYSE: TDOC), LivaNova (NASDAQ: LIVN) and Theratechnologies (NASDAQ: THTX)
- Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC – Research Report),
- 04/30/2020
|
Canaccord Genuity Sticks to Its Buy Rating for Boston Scientific (BSX)
- In a report released today, Jason Mills from Canaccord Genuity maintained a Buy rating on Boston Scientific (BSX), with a price target of $42.00. The
- 04/30/2020
|
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Blueprint Medicines (BPMC)
- There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Atricure (ATRC) and Blueprint Medicines (BPMC) with bullish
- 04/30/2020
|
BBVA USA Bancshares Inc. Purchases 5,192 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)
- BBVA USA Bancshares Inc. boosted its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 30.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,082 shares of the medical instruments supplier’s stock after acquiring an additional 5,192 shares during the quarter. BBVA USA […]
- 04/30/2020
|
Boston Scientific (BSX) Receives a Hold from Oppenheimer
- In a report released today, Steven Lichtman from Oppenheimer maintained a Hold rating on Boston Scientific (BSX), with a price target of $41.00. The
- 04/30/2020
|
Boston Scientific (BSX) Receives a Hold from Oppenheimer
- In a report released today,
Steven Lichtman
from Oppenheimer maintained a
Hold
rating on Boston Scientific (
BSX
–
Research Report
), with a price target of
$41.00
. The company’s shares closed last Wednesday at $37.43.
According to
TipRanks.com
, Li
- 04/30/2020
|
Dexcom (DXCM) Received its Third Buy in a Row
- According to TipRanks.com, Lichtman 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -4.1% and a 49.5% success rate.
- 04/29/2020
|
Dexcom (DXCM) Received its Third Buy in a Row
- According to TipRanks.com, Lichtman ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
- 04/29/2020
|
Zimmer Biomet Holdings (ZBH) Received its Third Buy in a Row
- After Wells Fargo and Goldman Sachs gave Zimmer Biomet Holdings (NYSE: ZBH) a Buy rating last month, the company received another Buy, this time from
- 04/29/2020
|
Zimmer Biomet Holdings (ZBH) Received its Third Buy in a Row
- After Wells Fargo and Goldman Sachs gave Zimmer Biomet Holdings (NYSE: ZBH) a Buy rating last month, the company received
- 04/29/2020
|
Zimmer Biomet Holdings (ZBH) Received its Third Buy in a Row
- After Wells Fargo and Goldman Sachs gave Zimmer Biomet Holdings (NYSE: ZBH) a Buy rating last month, the company received another Buy, this time from
- 04/28/2020
|
Zimmer Biomet Holdings (ZBH) Received its Third Buy in a Row
- After Wells Fargo and Goldman Sachs gave Zimmer Biomet Holdings (NYSE: ZBH) a Buy rating last month, the company received
- 04/28/2020
|
Tandem Diabetes Care (TNDM) Gets a Buy Rating from Raymond James
- In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Tandem Diabetes Care (TNDM), with a price target of $81.00. The
- 04/27/2020
|
Tandem Diabetes Care (TNDM) Gets a Buy Rating from Raymond James
- In a report released today,
Jayson Bedford
from Raymond James maintained a
Buy
rating on Tandem Diabetes Care (
TNDM
–
Research Report
), with a price target of
$81.00
. The company’s shares closed last Monday at $75.63.
According to
TipRanks.com
, B
- 04/27/2020
|
Raymond James Maintains a Buy Rating on Insulet (PODD)
- In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Insulet (PODD), with a price target of $220.00. The company's
- 04/27/2020
|
Analysts Offer Insights on Healthcare Companies: Flexion Therapeutics (FLXN) and Dexcom (DXCM)
- There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Flexion Therapeutics (FLXN) and Dexcom (DXCM) with bullish
- 04/27/2020
|
Analysts Offer Insights on Healthcare Companies: Flexion Therapeutics (NASDAQ: FLXN) and Dexcom (NASDAQ: DXCM)
- There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Flexion Therapeutics (
FLXN
–
Research Report
) and Dexcom (
DXCM
–
Research Report
) with bullish sentiments.
Flexion Therapeutics (FLXN)
In a report rele
- 04/27/2020
|
Raymond James Boosts Merit Medical Systems (NASDAQ:MMSI) Price Target to $46.00
- Merit Medical Systems (NASDAQ:MMSI) had its price objective hoisted by Raymond James from $44.00 to $46.00 in a research report released on Friday morning, BenzingaRatingsTable reports. Raymond James currently has an outperform rating on the medical instruments supplier’s stock. MMSI has been the topic of a number of other research reports. Oppenheimer restated a buy […]
- 04/27/2020
|
Piper Sandler Equities Analysts Decrease Earnings Estimates for Merit Medical Systems, Inc. (NASDAQ:MMSI)
- Merit Medical Systems, Inc. (NASDAQ:MMSI) – Equities researchers at Piper Sandler lowered their FY2021 earnings estimates for shares of Merit Medical Systems in a research note issued on Thursday, April 23rd. Piper Sandler analyst M. O’brien now anticipates that the medical instruments supplier will earn $1.54 per share for the year, down from their prior […]
- 04/27/2020
|
Merit Medical Systems Shows Market Leadership With Jump To 88 RS Rating
|
Kaskela Law LLC Announces Stockholder Investigation of Merit Medical Systems, Inc. (MMSI) and Encourages Long-Term Investors to Contact the Firm
- PHILADELPHIA, PA / ACCESSWIRE / April 25, 2020 / Kaskela Law LLC is investigating Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (NASDAQ:MMSI) on behalf of the Company's ...
- 04/26/2020
|
Merit Medical Systems (NASDAQ:MMSI) Raised to Buy at Barrington Research
- Merit Medical Systems (NASDAQ:MMSI) was upgraded by research analysts at Barrington Research to a “buy” rating in a research report issued on Friday, TipRanks reports. The firm presently has a $42.00 price target on the medical instruments supplier’s stock. Barrington Research’s price target would suggest a potential upside of 4.45% from the stock’s previous close. […]
- 04/25/2020
|
Merit Medical Systems (NASDAQ:MMSI) Trading Up 6.2% on Better-Than-Expected Earnings
- Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) were up 6.2% on Friday following a stronger than expected earnings report. The company traded as high as $43.00 and last traded at $40.21, approximately 792,734 shares traded hands during mid-day trading. An increase of 20% from the average daily volume of 661,430 shares. The stock had previously […]
- 04/25/2020
|
Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $46
|
Merit Medical Systems shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.
|
Merit Medical (MMSI) Tops Q1 Earnings and Revenue Estimates
- Merit Medical Systems (MMSI) has registered an increase in revenues at both its key operating segments in Q1
- 04/24/2020
|
Merit Medical (MMSI) Tops Q1 Earnings and Revenue Estimates
- Merit Medical Systems (MMSI) has registered an increase in revenues at both its key operating segments in Q1
- 04/24/2020
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Merit Medical Systems, Inc. - MMSI
- Pomerantz LLP is investigating claims on behalf of investors of Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI). The investigation concerns whether Merit Medical and certain of its officers and/or directors have breached fiduciary duties owed to the company and its investors
- 04/24/2020
|
Merit Medical upgraded to Outperform from Market Perform at Barrington MMSI
- Merit Medical upgraded to Outperform from Market Perform at Barrington Barrington MMSI
- 04/24/2020
|
Merit Medical Systems (MMSI) Receives a Buy from Barrington
- In a report released today, Michael Petusky from Barrington maintained a Buy rating on Merit Medical Systems (MMSI), with a price target of $42.00. The
- 04/24/2020
|
Merit Medical Systems (MMSI) Receives a Buy from Barrington
- In a report released today, Michael Petusky from Barrington maintained a Buy rating on Merit Medical Systems (MMSI – Research
- 04/24/2020
|
Wells Fargo Maintains Underweight on Merit Medical Systems, Raises Price Target to $37
|
The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO
- Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks hitting 52-week highs April 23.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) * Chembio Diagnostics Inc (NASDAQ: CEMI) * Cue Biopharma Inc (NASDAQ: CUE) * Eli Lilly And Co (NYSE: LLY
- 04/24/2020
|
Oppenheimer Assigns a Buy Rating on Merit Medical Systems (MMSI)
- In a report released today, Steven Lichtman from Oppenheimer assigned a Buy rating to Merit Medical Systems (MMSI), with a price target of $46.00. The
- 04/24/2020
|
Oppenheimer Assigns a Buy Rating on Merit Medical Systems (MMSI)
- In a report released today,
Steven Lichtman
from Oppenheimer assigned a
Buy
rating to Merit Medical Systems (
MMSI
–
Research Report
), with a price target of
$46.00
. The company’s shares closed last Thursday at $37.86.
According to
TipRanks.com
, L
- 04/24/2020
|
Merit Medical Systems (MMSI) Q1 2020 Earnings Call Transcript
- MMSI earnings call for the period ending March 31, 2020.
- 04/24/2020
|
Merit Medical Systems (MMSI) Receives a Rating Update from a Top Analyst
- Canaccord Genuity analyst Jason Mills maintained a Buy rating on Merit Medical Systems (MMSI) yesterday and set a price target of $40.00. The company's
- 04/24/2020
|
Merit Medical Systems (MMSI) Receives a Rating Update from a Top Analyst
- Canaccord Genuity analyst Jason Mills maintained a Buy rating on Merit Medical Systems (MMSI – Research Report) yesterday and set
- 04/24/2020
|
Analysts' Top Healthcare Picks: Edwards Lifesciences (EW), AxoGen (AXGN)
- There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Edwards Lifesciences (EW) and AxoGen (AXGN) with bullish
- 04/24/2020
|
Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), AxoGen (AXGN)
- There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Edwards Lifesciences (
EW
–
Research Report
) and AxoGen (
AXGN
–
Research Report
) with bullish sentiments.
Edwards Lifesciences (EW)
Canaccord Genuity an
- 04/24/2020
|
Tegna Contest Becomes First All-Virtual Board Fight
|
Piper continues to recommend buying Merit Medical after Q1 results MMSI
- Piper continues to recommend buying Merit Medical after Q1 results Piper Sandler MMSI
- 04/24/2020
|
Needham Sticks to Their Hold Rating for Merit Medical Systems (MMSI)
- In a report released today, Michael Matson from Needham maintained a Hold rating on Merit Medical Systems (MMSI). The company's shares closed last
- 04/24/2020
|
Needham Sticks to Their Hold Rating for Merit Medical Systems (MMSI)
- In a report released today, Michael Matson from Needham maintained a Hold rating on Merit Medical Systems (MMSI – Research
- 04/24/2020
|
Merit Medical Systems, Inc. Forecasted to Earn FY2020 Earnings of $1.15 Per Share (NASDAQ:MMSI)
- Merit Medical Systems, Inc. (NASDAQ:MMSI) – Stock analysts at Barrington Research issued their FY2020 earnings estimates for Merit Medical Systems in a research note issued on Monday, April 20th. Barrington Research analyst M. Petusky expects that the medical instruments supplier will post earnings per share of $1.15 for the year. Barrington Research currently has a […]
- 04/24/2020
|
Edited Transcript of MMSI earnings conference call or presentation 23-Apr-20 9:00pm GMT
- Q1 2020 Merit Medical Systems Inc Earnings Call
- 04/24/2020
|
Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q1 2020 Results - Earnings Call Transcript
- Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2020 Earnings Conference Call April 23, 2020 5:00 PM ET Company Participants Fred Lampropoulos - Chief Executive Of
- 04/24/2020
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Merit ...
|
Merit Medical (MMSI) Q1 Earnings and Revenues Beat Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 40.74% and 5.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 04/23/2020
|
Merit Medical (MMSI) Q1 Earnings and Revenues Beat Estimates
- Merit Medical (MMSI) delivered earnings and revenue surprises of 40.74% and 5.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 04/23/2020
|
BRIEF-Merit Medical Systems Reports Q1 Non-GAAP EPS Of $0.38
- Merit Medical Systems Inc:
- 04/23/2020
|
Merit Medical Withdraws FY20 Guidance
|
Merit Medical Reports Earnings for Quarter Ended March 31, 2020, Withdraws FY 2020 Guidance
- Q1 2020 worldwide revenue of $243.5 million, up 2.2% as reported over Q1 2019Q1 2020 core revenue on a constant currency basis* up 3.0% over Q1 2019Q1 2020 GAAP loss per share.
- 04/23/2020
|
Merit Medical Reports Earnings for Quarter Ended March 31, 2020,Withdraws FY 2020 Guidance
- Q1 2020 worldwide revenue of $243.5 million, up 2.2% as reported over Q1 2019Q1 2020 core revenue on a constant currency basis* up 3.0% over Q1 2019Q1 2020...
- 04/23/2020
|
Merit Medical Systems, Inc. to Host Earnings Call
- NEW YORK, NY / ACCESSWIRE / April 23, 2020 / Merit Medical Systems, Inc. (NASDAQ:MMSI) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on April 23, 2020 at ...
- 04/23/2020
|
Fly Intel: After-Hours Movers WWE;CYBE;TPH;VCRA;EW;MMSI;RHI;EBS;OZK;LLNW;INTC;EHTH;COF;ETFC;SKX;BA
- Fly Intel: After-Hours Movers WWE CYBE TPH VCRA EW MMSI RHI EBS OZK LLNW INTC EHTH COF ETFC SKX BA
- 04/23/2020
|
The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt
- Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks htitting 52-week highs April 22.)
Dr.Reddy's...
- 04/23/2020
|
Merit Medical withdraws FY20 guidance amid COVID-19 MMSI
- Merit Medical withdraws FY20 guidance amid COVID-19 MMSI
- 04/23/2020
|
Merit Medical reports Q1 EPS 38c, consensus 26c MMSI
- Merit Medical reports Q1 EPS 38c, consensus 26c MMSI
- 04/23/2020
|
Barrington Research Weighs in on Merit Medical Systems, Inc.'s Q2 2020 Earnings (NASDAQ:MMSI)
- Merit Medical Systems, Inc. (NASDAQ:MMSI) – Barrington Research reduced their Q2 2020 EPS estimates for Merit Medical Systems in a note issued to investors on Monday, April 20th. Barrington Research analyst M. Petusky now anticipates that the medical instruments supplier will post earnings of $0.26 per share for the quarter, down from their previous estimate […]
- 04/23/2020
|
Merit Medical Systems Q1 EPS $0.380 Beats $0.260 Estimate, Sales $243.500M Beat $233.230M Estimate
|
Here's Why You Should Retain NextGen Healthcare Stock Now
- NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and robust demand for other NextGen solutions.
- 04/22/2020
|
Here's Why You Should Retain NextGen Healthcare Stock Now
- NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and robust demand for other NextGen solutions.
- 04/22/2020
|
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Medtronic (MDT)
- Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIB) and Medtronic (MDT). Biogen (BIIB) Mizuho Securities
- 04/22/2020
|
Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and Medtronic (NYSE: MDT)
- Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (
BIIB
–
Research Report
) and Medtronic (
MDT
–
Research Report
).
Biogen (BIIB)
Mizuho Securities analyst
Salim Syed
maintained a
Hold
rating on Biogen today a
- 04/22/2020
|
Barrington Research Reiterates "Hold" Rating for Merit Medical Systems (NASDAQ:MMSI)
- Merit Medical Systems (NASDAQ:MMSI)‘s stock had its “hold” rating reaffirmed by equities research analysts at Barrington Research in a note issued to investors on Monday, AnalystRatings.com reports. MMSI has been the subject of several other reports. Needham & Company LLC restated a “hold” rating on shares of Merit Medical Systems in a research report on […]
- 04/22/2020
|
Here's Why You Should Hold on to HMS Holdings Stock Now
- HMS Holdings (HMSY) continues to benefit from strong PI solutions and TPM. However, stiff competition remains a concern.
- 04/21/2020
|
Here's Why You Should Hold on to HMS Holdings Stock Now
- HMS Holdings (HMSY) continues to benefit from strong PI solutions and TPM. However, stiff competition remains a concern.
- 04/21/2020
|
Exane Derivatives Takes $78,000 Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)
- Exane Derivatives purchased a new stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) in the first quarter, according to its most recent 13F filing with the SEC. The fund purchased 2,504 shares of the medical instruments supplier’s stock, valued at approximately $78,000. Other institutional investors and hedge funds have also recently added to or […]
- 04/21/2020
|
Disinfection Cap Market Size Worth $397.9 Million By 2027 | CAGR: 3.7%: Grand View Research, Inc.
- The global disinfection cap market size is expected to reach USD 397.9 million by 2027, expanding at a CAGR of 3.7%, according to a new report by Grand View Research, Inc. Increasing prevalence of hospital acquired diseases and rising hospital admissions are the key driving factors for the market. Hospital-acquired
- 04/21/2020
|
Were Hedge Funds Right About Central Garden & Pet Co (CENT)?
- "I have been following Dr. Inan Dogan since this outbreak, and he is a phenomenally intelligent researcher. One month ago, Dr. Dogan's prediction that the total U.S. death toll would be 20,000+ by April 15th was deemed "radical". His Recession is Imminent article in February was very
- 04/21/2020
|
Were Hedge Funds Right About Veoneer, Inc. (VNE)?
- "I have been following Dr. Inan Dogan since this outbreak, and he is a phenomenally intelligent researcher. One month ago, Dr. Dogan's prediction that the total U.S. death toll would be 20,000+ by April 15th was deemed "radical". His Recession is Imminent article in February was very
- 04/21/2020
|
Do Hedge Funds Regret Betting On The Cheesecake Factory Incorporated (CAKE)?
- "I have been following Dr. Inan Dogan since this outbreak, and he is a phenomenally intelligent researcher. One month ago, Dr. Dogan's prediction that the total U.S. death toll would be 20,000+ by April 15th was deemed "radical". His Recession is Imminent article in February was very
- 04/21/2020
|
Benzinga Pro's Top 5 Stocks To Watch For Tues., Apr. 21, 2020: FLIR, TWOU, HCAT, PTON, MMSI
|
Merit Medical Systems Shows Rising Relative Strength; Still Shy Of Key Benchmark
- A Relative Strength Rating upgrade for Merit Medical Systems shows improving technical performance. Will it continue?
- 04/20/2020
|
Masimo Collaborates With Samsung to Help Fight Coronavirus
- Masimo (MASI) and Samsung Electronics America collaborate to bring Masimo SafetyNet Patient App on the latter's select smartphones for faster distribution of Masimo SafetyNet to COVID-19 patients.
- 04/20/2020
|
Here's Why You Should Hold on to Cerner (CERN) Stock Now
- Cerner (CERN) continues to gain from solid prospects in EHR and strategic deals. However, margin contraction remains a woe.
- 04/20/2020
|
Merit Medical designs, produces sample collection and transport kit MMSI
- Merit Medical designs, produces sample collection and transport kit MMSI
- 04/20/2020
|
BRIEF-Merit Medical Systems Commenced Production Of A Sample Collection And Transport Kit Used To Collect Specimens With Suspected Presence Of Covid-19
- Merit Medical Systems Inc:
- 04/20/2020
|
MERIT MEDICAL SYSTEMS DESIGNS AND PRODUCES SAMPLE COLLECTION AND TRANSPORT KIT
- The kit will be produced at Merit’s facility in South Jordan, Utah, with other Utah companies providing various services. For the last several weeks, officials from Merit and the State of Utah have been working together in anticipation of an impending swab shortage. “We have directed resources to the development of this kit, and our engineers, technicians, marketers and production staff have responded by working tirelessly to bring this important product to market in 30 days,” said Fred P. Lampropoulos, Merit’s Chairman and CEO.
- 04/20/2020
|
MERIT MEDICAL SYSTEMS DESIGNS AND PRODUCES SAMPLE COLLECTION AND TRANSPORT KIT
- SOUTH JORDAN, Utah, April 20, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary...
- 04/20/2020
|
Merit Medical Systems (MMSI) Gets a Hold Rating from Barrington
- Barrington analyst Michael Petusky maintained a Hold rating on Merit Medical Systems (MMSI) today. The company's shares closed last Friday at $37.61.
- 04/20/2020
|
Merit Medical Systems (MMSI) Gets a Hold Rating from Barrington
- Barrington analyst
Michael Petusky
maintained a
Hold
rating on Merit Medical Systems (
MMSI
–
Research Report
) today. The company’s shares closed last Friday at $37.61.
According to
TipRanks.com
, Petusky is a 2-star analyst with an average return o
- 04/20/2020
|
Merit Medical Shares Up ~2% From Session Low; Hearing Wells Fargo Confirming Merit Medical Began Producing Sample Collection, Transport Kit For COVID-19
|
The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision
- Biotech stocks staged a nice recovery along with the broader markets in the week ended April 17.Apart from the broader market sentiment, big moves in biopharma companies such as Johnson & Johnson (NYSE: JNJ) and Gilead Sciences, Inc. (NASDAQ: GILD) also supported sentiment. The former reported strongly
- 04/19/2020
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merit Medical Systems, Inc. - MMSI
- Pomerantz LLP is investigating claims on behalf of investors of Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI). The investigation concerns whether Merit Medical and certain of its officers and/or directors have breached fiduciary duties owed to the company and its investors. If you are a shareholder of Merit Medical and are interested in obtaining additional information regarding this investigation, you are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext.
- 04/19/2020
|
612,574 Shares in Merit Medical Systems, Inc. (NASDAQ:MMSI) Bought by Norges Bank
- Norges Bank acquired a new position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 612,574 shares of the medical instruments supplier’s stock, valued at approximately $19,125,000. Norges Bank owned 1.11% of Merit […]
- 04/19/2020
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Merit ...
|
